Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|March 20, 2019
Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?Diane C Ling, Philip A Sutera, Nick A Iarrobino, et al.
Breast Disease|September 24, 2016
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancerAtilla Soran, Rohit Bhargava, Ronald Johnson, et al.
American Journal of Clinical Oncology|April 7, 2007
Placement technique and the early complications of balloon breast brachytherapy: Magee-Womens Hospital experienceAtilla Soran, Turkkan Evrensel, Sushil Beriwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27Harry D Bear, Stewart Anderson, Ann Brown, et al.
Annals of Surgical Oncology|July 27, 2021
Cutting Instruments to Cut Costs: A Simple Initiative with Breast Surgical Operating Room Trays that Resulted in Substantial SavingsJandie L Schwartz, Lindsey Kirkpatrick, Karalyn E Hillebrecht, et al.
Breast Care (Basel, Switzerland)|May 20, 2021
A Novel First-Line Treatment Alternative for Noncomplicated Idiopathic Granulomatous Mastitis: Combined İntralesional Steroid İnjection with Topical Steroid AdministrationOsman Toktas, Can Konca, Didem Can Trabulus, et al.
Annals of Surgical Oncology|August 5, 2020
Post-operative Nausea and Analgesia Following Total Mastectomy is Improved After Implementation of an Enhanced Recovery ProtocolKate H Dinh, Priscilla F McAuliffe, Michael Boisen, et al.
Clinical Breast Cancer|September 11, 2024
De-Escalating the Extent of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma in Situ Undergoing MastectomyAdil Ayub, Kazim Senol, Makris Eleftherios, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancerRohit Bhargava, David J Dabbs, Sushil Beriwal, et al.
The Breast Journal|April 28, 2007
Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situLisa A Rutstein, Ronald R Johnson, William R Poller, et al.
Pageof 12